English
 
Help Privacy Policy Disclaimer
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT
  GluA4-targeted AAV vectors deliver genes selectively to interneurons while relying on the AAV receptor for entry

Hartmann, J., Thalheimer, F. B., Höpfner, F., Kerzel, T., Khodosevich, K., García-González, D., et al. (2019). GluA4-targeted AAV vectors deliver genes selectively to interneurons while relying on the AAV receptor for entry. Molecular Therapy: Methods & Clinical Development, 14, 252-260. doi:10.1016/j.omtm.2019.07.004.

Item is

Files

show Files
hide Files
:
Hartmann_2019_Glu4-TargetedAAV.pdf (Publisher version), 3MB
Name:
Hartmann_2019_Glu4-TargetedAAV.pdf
Description:
-
OA-Status:
Gold
Visibility:
Public
MIME-Type / Checksum:
application/pdf / [MD5]
Technical Metadata:
Copyright Date:
2019
Copyright Info:
Copyright © 2019 Paul-Ehrlich-Institut

Locators

show
hide
Description:
-
OA-Status:
Gold

Creators

show
hide
 Creators:
Hartmann, Jessica, Author
Thalheimer, Frederic B., Author
Höpfner, Felix, Author
Kerzel, Thomas, Author
Khodosevich, Konstantin, Author
García-González, Diego, Author
Monyer, Hannah, Author
Diester, Ilka, Author
Büning, Hildegard, Author
Carette, Jan E., Author
Fries, Pascal1, 2, Author                 
Buchholz, Christian J., Author
Affiliations:
1Ernst Strüngmann Institute (ESI) for Neuroscience in Cooperation with Max Planck Society, Max Planck Society, Deutschordenstr. 46, 60528 Frankfurt, DE, ou_2074314              
2Fries Lab, Ernst Strüngmann Institute (ESI) for Neuroscience in Cooperation with Max Planck Society, Max Planck Society, Deutschordenstraße 46, 60528 Frankfurt, DE, ou_3381216              

Content

show
hide
Free keywords: Aav Aavr GluA4 Pv interneuron parvalbumin targeting
 Abstract: Selective gene delivery into subtypes of interneurons remains an important challenge in vector development. Adeno-associated virus (AAV) vector particles are especially promising for intracerebral injections. For cell entry, AAV2 particles are supposed to attach to heparan-sulfate proteoglycans (HSPGs) followed by endocytosis via the AAV receptor (AAVR). Here, we assessed engineered AAV particles deficient in HSPG attachment but competent in recognizing the glutamate receptor 4 (GluA4, also known as GluRD or GRIA4) through a displayed GluA4-specific DARPin (designed ankyrin repeat protein). When injected into the mouse brain, histological evaluation revealed that in various regions, more than 90% of the transduced cells were interneurons, mainly of the parvalbumin-positive subtype. Although part of the selectivity was mediated by the DARPin, the chosen spleen focus-forming virus (SFFV) promoter had contributed as well. Further analysis revealed that the DARPin mediated selective attachment to GluA4-positive cells, whereas gene delivery required expression of AAVR. Our data suggest that cell selectivity of AAV particles can be modified rationally and efficiently through DARPins, but expression of the AAV entry receptor remains essential.

Details

show
hide
Language(s):
 Dates: 2019-07-232019-09-13
 Publication Status: Issued
 Pages: -
 Publishing info: -
 Table of Contents: -
 Rev. Type: Peer
 Identifiers: DOI: 10.1016/j.omtm.2019.07.004
 Degree: -

Event

show

Legal Case

show

Project information

show

Source 1

show
hide
Title: Molecular Therapy: Methods & Clinical Development
  Abbreviation : Mol Ther Methods Clin Dev
Source Genre: Journal
 Creator(s):
Affiliations:
Publ. Info: -
Pages: - Volume / Issue: 14 Sequence Number: - Start / End Page: 252 - 260 Identifier: ISSN: 2329-0501
CoNE: https://pure.mpg.de/cone/journals/resource/961066780010